公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
Elecsys CalSet hGH10287410929ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys hGH10287410930ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Cobas b 123 Fluid Pack COOX10287410931ROCHE DIAGNÓSTICA BRASIL LTDAIII26/10/2036
PreciControl HSV10287410933ROCHE DIAGNÓSTICA BRASIL LTDAIII28/03/2036
PreciControl CMV IgG Avidity10287410935ROCHE DIAGNÓSTICA BRASIL LTDAIV25/04/2036
Anti-TPO CalSet10287410939ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys Anti-TPO without CalSet10287410940ROCHE DIAGNÓSTICA BRASIL LTDAII现有
COBAS B 123 POC SYSTEM10287410948ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Total MPA Controls10287410953ROCHE DIAGNÓSTICA BRASIL LTDAIII25/08/2035
Total MPA Calibrators10287410954ROCHE DIAGNÓSTICA BRASIL LTDAIII25/08/2035
PreciControl Varia10287410955ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Família de Corantes Ventana10287410956ROCHE DIAGNÓSTICA BRASIL LTDAI现有
BILD2 - Bilirubin Direct Gen.210287410957ROCHE DIAGNÓSTICA BRASIL LTDAII现有
PTH (1-84) CalSet10287410962ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Cobas® DNA Sample Preparation Kit10287410963ROCHE DIAGNÓSTICA BRASIL LTDAI现有
AAGP2 - Tina-quant alfa-1-Acid Glycoprotein Gen.210287410964ROCHE DIAGNÓSTICA BRASIL LTDAII现有
COBAS® TaqMan® HIV-1 Test, version 2.010287410965ROCHE DIAGNÓSTICA BRASIL LTDAIII26/12/2026
Cobas® 4800 BRAF V600 Mutation Test10287410968ROCHE DIAGNÓSTICA BRASIL LTDAIII02/01/2037
cobas® KRAS Mutation Test10287410969ROCHE DIAGNÓSTICA BRASIL LTDAIII02/01/2037
cobas® EGFR Mutation Test10287410970ROCHE DIAGNÓSTICA BRASIL LTDAIII12/03/2027
PreciControl Toxo IgG Avidity10287410971ROCHE DIAGNÓSTICA BRASIL LTDAIV14/05/2027
Elecsys Toxo IgG Avidity10287410972ROCHE DIAGNÓSTICA BRASIL LTDAIV14/05/2027
Benzodiazepines II10287410973ROCHE DIAGNÓSTICA BRASIL LTDAII现有
ONLINE DAT Amphetamines II10287410975ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Calcium Gen.210287410977ROCHE DIAGNÓSTICA BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家